These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 18815046

  • 1. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.
    Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia FL.
    J Clin Neurosci; 2008 Dec; 15(12):1350-3. PubMed ID: 18815046
    [Abstract] [Full Text] [Related]

  • 2. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
    Rojana-udomsart A, Needham M, Luo YB, Fabian V, Walters S, Zilko PJ, Mastaglia FL.
    Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota.
    Wilson FC, Ytterberg SR, St Sauver JL, Reed AM.
    J Rheumatol; 2008 Mar; 35(3):445-7. PubMed ID: 18203321
    [Abstract] [Full Text] [Related]

  • 7. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.
    Scott AP, Laing NG, Mastaglia F, Needham M, Walter MC, Dalakas MC, Allcock RJ.
    J Neuroimmunol; 2011 Jun; 235(1-2):77-83. PubMed ID: 21543121
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study.
    Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjärne J, Grøvle L, Gran JT, Molberg Ø.
    Eur J Neurol; 2015 Apr; 22(4):672-e41. PubMed ID: 25530508
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.
    Needham M, Mastaglia FL.
    Lancet Neurol; 2007 Jul; 6(7):620-31. PubMed ID: 17582362
    [Abstract] [Full Text] [Related]

  • 15. [Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)].
    Suzuki N, Tateyama M, Warita H, Izumi R, Nishino I, Aoki M.
    Rinsho Shinkeigaku; 2011 Nov; 51(11):964-6. PubMed ID: 22277440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.
    Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA.
    Brain; 2011 Nov; 134(Pt 11):3167-75. PubMed ID: 21908393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.